Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.9% of adults in Tacoma have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Census population 219,346. Washington Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Tacoma clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Tacoma storefront.
Orthobiologic Treatments for Your Practice in Tacoma, WA for clinics & physicians. Premium orthobiologic t… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.9% of adults in Tacoma have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Census city-proper population is 219,346. If you are adding orthobiologic treatments, start with that epidemiology and with Noridian Healthcare Solutions (JF) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.9% of adults in Tacoma have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Adult obesity in Tacoma is 37.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 25.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, AZ, ID, MT, ND, OR, SD, UT, WY. Washington State Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JF articles mapped. 9.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 10.9% of adults — 1.1 points below the U.S. 12% figure. Obesity is 37.3%; arthritis is 25.1%. That is place-level BRFSS modeling, not a clinic census and not a Tacoma trial.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Washington. There is no Tacoma storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers orthobiologic treatments for your practice and which products they use.
If you operate in Washington and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Tacoma tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Tacoma, WA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Tacoma is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Tacoma — 1.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Washington Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, UT, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Tacoma. Useful for joint-program math; still needs a diagnosis and privileging.
No Tacoma storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.